IMMUNIC INC (IMUX) Stock Income Statement
NASDAQ:IMUX - Nasdaq - US4525EP1011 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 98.05M | 99.22M | 86.52M | 74.42M | 48.97M | |||
| Research and Development | 80.05M | 83.22M | 71.26M | 61.12M | 38.64M | |||
| Selling, General, and Administrative Expenses | 18.01M | 16.01M | 15.26M | 13.30M | 10.33M | |||
| Operating Income | -98.05M | -99.22M | -86.52M | -74.42M | -48.97M | |||
| Interest Income/Expense | 3.39M | 3.08M | 1.04M | 70.00K | 60.00K | |||
| Other Income/Expense | -5.84M | 2.54M | -1.96M | -1.35M | 4.90M | |||
| Non Recurring Items | N/A | 0.00 | -32.97M | -17.25M | N/A | |||
| Income Before Taxes | -100.51M | -93.61M | -120.41M | -92.95M | -44.02M | |||
| Net Income | -100.51M | -93.61M | -120.41M | -92.95M | -44.02M | |||
| EBITDA | -97.92M | -99.11M | -86.44M | -74.33M | -48.93M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.00 | -2.11 | -3.78 | -3.93 | -2.81 | |||
| Non GAAP EPS | -1.00 | -2.11 | -3.77 | -3.93 | -2.85 | |||
| Statistics | ||||||||
All data in USD